Back
Protagonist Therapeutics Vs. New Oriental Education & Technology Group Industry Stock Comparison
Buy
57
PTGX
Protagonist Therapeutics
Last Price:
26.09
Seasonality Move:
28.29%
Buy
68
EDU
New Oriental Education & Technology Group
Last Price:
84.75
Seasonality Move:
5.23%
Buy
57
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $26.09. The Score for PTGX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
New Oriental Education & Technology Group (EDU)
is a Buy
Is New Oriental Education & Technology Group a Buy, Sell or Hold?
- The current New Oriental Education & Technology Group [EDU] share price is $84.75. The Score for EDU is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- EDU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $26.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight selling pressure.
EDU Stock Price Chart
What is New Oriental Education & Technology Group's stock price today?
-
The New Oriental Education & Technology Group share price today is $84.75
The current trend is relatively stagnant and EDU is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.66 | Sell |
| Relative Strength Index (14 RSI): | 46.72 | Sell |
| Chaikin Money Flow: | -63474 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.39 - 27.87) | Sell |
| Bollinger Bands (100): | (23.44 - 29.1) | Sell |
EDU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.88 | Sell |
| Relative Strength Index (14 RSI): | 50.45 | Buy |
| Chaikin Money Flow: | 1859315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (81.11 - 87.91) | Buy |
| Bollinger Bands (100): | (75.92 - 90.86) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.42 | Buy |
| 20-day SMA: | 26.29 | Sell |
| 50-day SMA: | 28.09 | Sell |
| 200-day SMA: | 21.93 | Buy |
| 8-day EMA: | 25.68 | Buy |
| 20-day EMA: | 26.24 | Sell |
| 50-day EMA: | 26.79 | Sell |
| 200-day EMA: | 23.61 | Buy |
EDU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.43 | Buy |
| 20-day SMA: | 84.05 | Buy |
| 50-day SMA: | 88.27 | Sell |
| 200-day SMA: | 72.21 | Buy |
| 8-day EMA: | 81.9 | Buy |
| 20-day EMA: | 83.67 | Buy |
| 50-day EMA: | 85.14 | Sell |
| 200-day EMA: | 73.15 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.
New Oriental Education & Technology Group Earnings Growth & EDU Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.57 per share, an increase this year of $0.92 per share, and an increase next year of $1.21 per share.
Protagonist Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
New Oriental Education & Technology Group Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||